- Top Workplaces
- Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc.
At Sarepta, we are in a daily race to save lives stolen or impacted by rare disease. Patients can’t wait for the next breakthrough in medical research. So, neither will we.
We’re engineering precision genetic medicine to reclaim futures otherwise impacted or cut short by ushering in a new era of drug development, with the goal of shortening the time from lab to patient. We’re building the world’s largest gene therapy manufacturing capacity, and rethinking access and reimbursement models for revolutionary new treatments. Our platforms include gene therapy, RNA technologies, and gene editing.
While there may be as many as 7,000 rare diseases, only a small percentage have treatments. At Sarepta, we’re committed to pursuing some of the world’s most debilitating, prevalent, and complex rare genetic diseases. That is why we are relentless in our dedication: leverage the best science to help as many patients as possible. Among the diseases we’re pursuing Duchenne muscular dystrophy and six forms of limb-girdle muscular dystrophy. At Sarepta, we follow the science and continuously evaluate other diseases and modalities to pursue or what challenges we need to overcome.
We’re engineering precision genetic medicine to reclaim futures otherwise impacted or cut short by ushering in a new era of drug development, with the goal of shortening the time from lab to patient. We’re building the world’s largest gene therapy manufacturing capacity, and rethinking access and reimbursement models for revolutionary new treatments. Our platforms include gene therapy, RNA technologies, and gene editing.
While there may be as many as 7,000 rare diseases, only a small percentage have treatments. At Sarepta, we’re committed to pursuing some of the world’s most debilitating, prevalent, and complex rare genetic diseases. That is why we are relentless in our dedication: leverage the best science to help as many patients as possible. Among the diseases we’re pursuing Duchenne muscular dystrophy and six forms of limb-girdle muscular dystrophy. At Sarepta, we follow the science and continuously evaluate other diseases and modalities to pursue or what challenges we need to overcome.
Purpose
We are the leaders in precision genetic medicine. We are upending convention. And we are in a furious rush, driven by a sense of responsibility that we can save lives through our unshakable bias to action, our ability to focus on getting important work done, and powered by our push to move with urgency.
Mission
Armed with the most advanced science in genetic medicine, we are in a daily race to rescue lives otherwise stolen by rare disease. At Sarepta, every day is another 24 hours to stand up for patients, advance technology, challenge convention and drag tomorrow into today.
Values
- Patients First
- The patient is the reason we exist, the heart of every decision we make and the beneficiary of our every innovation.
Recent Awards
2020
2018
Company Snapshots
